L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer

Jpn J Cancer Res. 2000 Feb;91(2):199-203. doi: 10.1111/j.1349-7006.2000.tb00932.x.

Abstract

L-myc polymorphism is a representative genetic trait related to an individual's susceptibility to several cancers. However, there have been no reports concerning the association between esophageal cancer and L-myc polymorphism. To analyze the distribution of polymorphism in Japanese patients with esophageal cancer, a molecular genotyping method using a polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) was used. Based on an analysis of 65 Japanese patients with esophageal cancer and 107 healthy control subjects, a significant difference was observed in either the distribution of genotypes (P=0.012) or of allele frequencies between the two groups (P=0.004). The relative risk of esophageal cancer for genotypes including the shorter allele was 2.9 compared to the longer allele homozygote. Furthermore, the patients with S-allele had a tendency for poor prognosis among those with three genotypes. A significant difference between the distribution of genotypes and the incidence of lymph node metastasis was found based on the clinicopathological features of the cancers. These results suggest that L-myc polymorphism may be implicated as a genetic trait affecting an individual's susceptibility to esophageal cancer, at least among Japanese patients.

MeSH terms

  • Esophageal Neoplasms / genetics*
  • Esophageal Neoplasms / mortality
  • Genes, myc*
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Polymorphism, Restriction Fragment Length*
  • Survival Rate